These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

687 related items for PubMed ID: 18090241

  • 1. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas.
    Ishida M, Egawa S, Aoki T, Sakata N, Mikami Y, Motoi F, Abe T, Fukuyama S, Sunamura M, Unno M, Moriya T, Horii A, Furukawa T.
    Pancreas; 2007 Nov; 35(4):348-52. PubMed ID: 18090241
    [Abstract] [Full Text] [Related]

  • 2. Pancreatic juice cytology and subclassification of intraductal papillary mucinous neoplasms of the pancreas.
    Hibi Y, Fukushima N, Tsuchida A, Sofuni A, Itoi T, Moriyasu F, Mukai K, Aoki T.
    Pancreas; 2007 Mar; 34(2):197-204. PubMed ID: 17312458
    [Abstract] [Full Text] [Related]

  • 3. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types.
    Ban S, Naitoh Y, Mino-Kenudson M, Sakurai T, Kuroda M, Koyama I, Lauwers GY, Shimizu M.
    Am J Surg Pathol; 2006 Dec; 30(12):1561-9. PubMed ID: 17122512
    [Abstract] [Full Text] [Related]

  • 4. Intraductal papillary-mucinous neoplasms of the gastric and intestinal types may have less malignant potential than the pancreatobiliary type.
    Takasu N, Kimura W, Moriya T, Hirai I, Takeshita A, Kamio Y, Nomura T.
    Pancreas; 2010 Jul; 39(5):604-10. PubMed ID: 20124938
    [Abstract] [Full Text] [Related]

  • 5. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification.
    Serikawa M, Sasaki T, Fujimoto Y, Kuwahara K, Chayama K.
    J Clin Gastroenterol; 2006 Oct; 40(9):856-62. PubMed ID: 17016145
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The expression of MUC4 and MUC5AC is related to the biologic malignancy of intraductal papillary mucinous neoplasms of the pancreas.
    Kanno A, Satoh K, Kimura K, Hirota M, Umino J, Masamune A, Satoh A, Asakura T, Egawa S, Sunamura M, Endoh M, Shimosegawa T.
    Pancreas; 2006 Nov; 33(4):391-6. PubMed ID: 17079945
    [Abstract] [Full Text] [Related]

  • 8. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.
    Michaels PJ, Brachtel EF, Bounds BC, Brugge WR, Pitman MB.
    Cancer; 2006 Jun 25; 108(3):163-73. PubMed ID: 16550572
    [Abstract] [Full Text] [Related]

  • 9. Endoscopic ultrasound-guided fine-needle aspiration cytology in the diagnosis of intraductal papillary mucinous neoplasms of the pancreas. A study of 8 cases.
    Salla C, Chatzipantelis P, Konstantinou P, Karoumpalis I, Sakellariou S, Pantazopoulou A, Manika Z.
    JOP; 2007 Nov 09; 8(6):715-24. PubMed ID: 17993724
    [Abstract] [Full Text] [Related]

  • 10. Clinical implication of morphological subtypes in management of intraductal papillary mucinous neoplasm.
    Yamada S, Fujii T, Shimoyama Y, Kanda M, Nakayama G, Sugimoto H, Koike M, Nomoto S, Fujiwara M, Nakao A, Kodera Y.
    Ann Surg Oncol; 2014 Jul 09; 21(7):2444-52. PubMed ID: 24562937
    [Abstract] [Full Text] [Related]

  • 11. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A, Arisaka Y, Hara S, Matsumoto I, Takenaka M, Sakai A, Shiomi H, Matsuki N, Sugimoto M, Fujita T, Hayakumo T, Ku Y, Ogino S, Azuma T, Kutsumi H.
    Pancreatology; 2013 Jul 09; 13(6):583-8. PubMed ID: 24280573
    [Abstract] [Full Text] [Related]

  • 12. Comparison of histologic subtype and growth pattern in intraductal papillary-mucinous carcinoma of the pancreas.
    Sanada Y, Kunita S, Yoshida K.
    Oncol Rep; 2008 Jun 09; 19(6):1435-43. PubMed ID: 18497948
    [Abstract] [Full Text] [Related]

  • 13. Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis.
    Marchegiani G, Mino-Kenudson M, Ferrone CR, Warshaw AL, Lillemoe KD, Fernández-del Castillo C.
    J Am Coll Surg; 2015 May 09; 220(5):839-44. PubMed ID: 25840549
    [Abstract] [Full Text] [Related]

  • 14. Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas.
    Furukawa T, Hatori T, Fujita I, Yamamoto M, Kobayashi M, Ohike N, Morohoshi T, Egawa S, Unno M, Takao S, Osako M, Yonezawa S, Mino-Kenudson M, Lauwers GY, Yamaguchi H, Ban S, Shimizu M.
    Gut; 2011 Apr 09; 60(4):509-16. PubMed ID: 21193453
    [Abstract] [Full Text] [Related]

  • 15. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules.
    Sadakari Y, Ienaga J, Kobayashi K, Miyasaka Y, Takahata S, Nakamura M, Mizumoto K, Tanaka M.
    Pancreas; 2010 Mar 09; 39(2):232-6. PubMed ID: 19752768
    [Abstract] [Full Text] [Related]

  • 16. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
    Woo SM, Ryu JK, Lee SH, Yoo JW, Park JK, Kim YT, Yoon YB.
    Pancreas; 2008 Jan 09; 36(1):50-5. PubMed ID: 18192881
    [Abstract] [Full Text] [Related]

  • 17. MUC1 and HER2 might be associated with invasive phenotype of intraductal papillary mucinous neoplasm.
    Ohira G, Kimura K, Yamada N, Amano R, Nakata B, Doi Y, Murata A, Yashiro M, Tanaka S, Ohsawa M, Wakasa K, Hirakawa K.
    Hepatogastroenterology; 2013 Jan 09; 60(125):1067-72. PubMed ID: 23635475
    [Abstract] [Full Text] [Related]

  • 18. Increased K-ras mutation and expression of S100A4 and MUC2 protein in the malignant intraductal papillary mucinous tumor of the pancreas.
    Jang JY, Park YC, Song YS, Lee SE, Hwang DW, Lim CS, Lee HE, Kim WH, Kim SW.
    J Hepatobiliary Pancreat Surg; 2009 Jan 09; 16(5):668-74. PubMed ID: 19412570
    [Abstract] [Full Text] [Related]

  • 19. Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe?
    Jang JY, Kim SW, Lee SE, Yang SH, Lee KU, Lee YJ, Kim SC, Han DJ, Choi DW, Choi SH, Heo JS, Cho BH, Yu HC, Yoon DS, Lee WJ, Lee HE, Kang GH, Lee JM.
    Ann Surg Oncol; 2008 Jan 09; 15(1):199-205. PubMed ID: 17909912
    [Abstract] [Full Text] [Related]

  • 20. Current understanding of precursors to pancreatic cancer.
    Takaori K.
    J Hepatobiliary Pancreat Surg; 2007 Jan 09; 14(3):217-23. PubMed ID: 17520195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.